Position in MRK
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$4,957,915
+$537,017 QoQ
Shares Held
38,583
+5.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.48%
of 13F equity value
Holder Rank
#1,047
of 3,769 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Founders Capital Management holds $23,776,064 across 8 Drug Manufacturers - General names. MRK ranks #3 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,663 | $11,851,002 | |
| 2 | ABBV |
AbbVie Inc.
|
25,101 | $6,316,415 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
38,583 | $4,957,915 | |
| 4 | PFE |
Pfizer Inc
|
13,473 | $324,429 | |
| 5 | AMGN |
Amgen Inc
|
409 | $148,107 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,500 | $86,430 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
512 | $64,686 | |
| 8 | OGN |
Organon & Co.
|
2,000 | $27,080 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,957,915 | 38,583 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $4,420,898 | 36,752 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $3,786,833 | 35,976 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $3,065,711 | 36,527 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,923,774 | 36,935 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $3,306,848 | 36,841 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $4,359,213 | 43,820 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $5,142,223 | 45,282 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $5,515,785 | 44,554 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $5,927,853 | 44,925 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $4,959,537 | 45,492 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $4,709,756 | 45,748 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $5,310,132 | 46,019 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $4,960,752 | 46,628 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $5,205,552 | 46,918 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $4,040,492 | 46,917 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $4,308,785 | 47,261 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $2,032,132 | 24,767 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $1,898,142 | 24,767 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,905,165 | 25,365 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $2,134,008 | 27,440 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $2,077,962 | 26,955 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $2,209,008 | 27,005 | Shares | Sole | 2021-01-12 | |
| 2020-03-31 | $2,320,509 | 30,160 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||